Loading clinical trials...
Loading clinical trials...
Phase II Study of Depsipeptide in Metastatic Neuroendocrine Tumors
Conditions
Interventions
romidepsin
laboratory biomarker analysis
Locations
1
United States
Ohio State University Medical Center
Columbus, Ohio, United States
Start Date
March 1, 2004
Primary Completion Date
October 1, 2004
Last Updated
June 4, 2013
NCT00001276
NCT04452396
NCT04979611
NCT01010126
NCT02108782
NCT00937079
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions